La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Neuroprotective Agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neurophysiology < Neuroprotective Agents < Neuropsychiatry  Facettes :

List of bibliographic references indexed by Neuroprotective Agents

Number of relevant bibliographic references: 57.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000263 (2016) Michel Panisset ; Jean-Louis Stril ; Manon Bélanger ; Geneviève Lehoux ; Donna Coffin ; Sylvain ChouinardOpen-Label Study of Sleep Disturbances in Patients with Parkinson's Disease Treated with Rasagiline.
000346 (2016) Matthias Luz [Canada] ; Erich Mohr [Canada] ; H Christian Fibiger [Canada]GDNF-induced cerebellar toxicity: A brief review.
000603 (2015) Ronald B. Postuma ; Jean-Francois Gagnon ; Josie-Anne Bertrand ; Daphné Génier Marchand ; Jacques Y. MontplaisirParkinson risk in idiopathic REM sleep behavior disorder
000629 (2015) Jinghua Liu ; Arjun H. Banskota ; Alan T. Critchley ; Jeff Hafting ; Balakrishnan PrithivirajNeuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease
000678 (2015) Ross B. Mounsey [Royaume-Uni] ; Sarah Mustafa [Royaume-Uni] ; Lianne Robinson [Royaume-Uni] ; Ruth A. Ross [Canada] ; Gernot Riedel [Royaume-Uni] ; Roger G. Pertwee [Royaume-Uni] ; Peter Teismann [Royaume-Uni]Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
000731 (2015) Zaijun Zhang [République populaire de Chine] ; Guohui Li [République populaire de Chine] ; Samuel S W. Szeto [République populaire de Chine] ; Cheong Meng Chong [République populaire de Chine] ; Quan Quan [République populaire de Chine] ; Chen Huang [République populaire de Chine] ; Wei Cui [République populaire de Chine] ; Baojian Guo [République populaire de Chine] ; Yuqiang Wang [République populaire de Chine] ; Yifan Han [République populaire de Chine] ; K W Michael Siu [Canada] ; Simon Ming Yuen Lee [République populaire de Chine] ; Ivan K. Chu [République populaire de Chine]Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease.
000750 (2015) Joe Kakish ; Dongsoo Lee ; Jeremy S. LeeDrugs That Bind to α-Synuclein: Neuroprotective or Neurotoxic?
000967 (2014) Lynda Peterson [États-Unis] ; Kathleen P. Ismond [Canada] ; Elisha Chapman [Canada] ; Patrick Flood [Canada, États-Unis]Potential Benefits of Therapeutic Use of β2-Adrenergic Receptor Agonists in Neuroprotection and Parkinsonμs Disease
000985 (2014) Jackalina M. Van Kampen [Canada] ; David B. Baranowski [Canada] ; Christopher A. Shaw [Canada] ; Denis G. KayPanax ginseng is neuroprotective in a novel progressive model of Parkinson's disease.
000987 (2014) Krithika Muthukumaran [Canada] ; Samantha Leahy [Canada] ; Kate Harrison [Canada] ; Marianna Sikorska [Canada] ; Jagdeep K. Sandhu [Canada] ; Jerome Cohen [Canada] ; Corrine Keshan [Canada] ; Daniel Lopatin [Canada] ; Harvey Miller [Canada] ; Henryk Borowy-Borowski [Canada] ; Patricia Lanthier [Canada] ; Shelly Weinstock [États-Unis] ; Siyaram Pandey [Canada]Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease
000993 (2014) C H Carriere [Canada] ; N H Kang [Canada] ; L P Niles [Canada]Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
000995 (2014) Marianna Sikorska [Canada] ; Patricia Lanthier [Canada] ; Harvey Miller [Canada] ; Melissa Beyers [Canada] ; Caroline Sodja [Canada] ; Bogdan Zurakowski [Canada] ; Sandhya Gangaraju [Canada] ; Siyaram Pandey [Canada] ; Jagdeep K. Sandhu [Canada]Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson’s disease
000B12 (2014) Anne-Marie Arel-Dubeau [Canada] ; Fanny Longpré [Canada] ; Julie Bournival [Canada] ; Cindy Tremblay [Canada] ; Julie Demers-Lamarche [Canada] ; Pavlina Haskova [Canada, République tchèque] ; Everaldo Attard [Malte] ; Marc Germain [Canada] ; Maria-Grazia Martinoli [Canada]Cucurbitacin E Has Neuroprotective Properties and Autophagic Modulating Activities on Dopaminergic Neurons
000D01 (2013) Amaal Aldakheel ; Lorraine V. Kalia ; Anthony E. LangPathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
000F10 (2013) Anthony E. Lang [Canada] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Olivier Rascol [France]Trial designs used to study neuroprotective therapy in Parkinson's disease
001021 (2013) Pankaj A. Agarwal [Canada] ; A. Jon Stoessl [Canada]Biomarkers for trials of neuroprotection in Parkinson's disease
001130 (2012) Mélanie Bourque [Canada] ; Dean E. Dluzen ; Thérèse Di PaoloSignaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.
001133 (2012) Maria Xilouri [Grèce] ; Elli Kyratzi ; Pothitos M. Pitychoutis ; Zoi Papadopoulou-Daifoti ; Celine Perier ; Miquel Vila ; Matina Maniati ; Ayse Ulusoy ; Deniz Kirik ; David S. Park ; Keiji Wada ; Leonidas StefanisSelective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
001244 (2012) Moonhee Lee ; Byoung-Mog Kwon ; Byoung-Mok Kwon ; Kyoungho Suk ; Edith Mcgeer ; Patrick L. McgeerEffects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage.
001278 (2012) Jihane Ismaili [Canada] ; Martin Boisvert ; Fanny Longpré ; Julie Carange ; Céline Le Gall ; Maria-Grazia Martinoli ; Benoit DaoustBrassinosteroids and analogs as neuroprotectors: synthesis and structure-activity relationships.
001390 (2012) S. Al Sweidi [Canada] ; M. G. Sánchez [Canada] ; M. Bourque [Canada] ; M. Morissette [Canada] ; D. Dluzen [États-Unis] ; T. Di Paolo [Canada]Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Neuroprotective Agents" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Neuroprotective Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Neuroprotective Agents
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022